Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dasatinib (sprycel) (1 trial)
vandetanib (caprelsa) (1 trial)
Glioma (Phase 1)
Trials (1 total)
Trial APIs (2 total)